Brief: Homology Medicines Announces Presentations On Design Of Ongoing Gene Editing And Gene Therapy Trials For Pku And Hunter Syndrome At Acmg Annual Clinical Genetics Meeting
March 15 (Reuters) - Homology Medicines Inc FIXX.O :
* HOMOLOGY MEDICINES ANNOUNCES PRESENTATIONS ON DESIGN OF
ONGOING
GENE EDITING AND GENE THERAPY TRIALS FOR PKU AND HUNTER SYNDROME
AT ACMG ANNUAL CLINICAL GENETICS MEETING
Source text for Eikon: ID:nGNXbRSGCw
Further company coverage: FIXX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Q32 Bio
See all newsNASDAQ RESUMED AT 09:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM
Brief: Q32 Bio Reports Second Quarter 2026 Financial Results And Provides Corporate Update
Q32 Bio Inc. reports results for the quarter ended June 30 - Earnings Summary
Q32 Bio Inc expected to post a loss of 54 cents a share - Earnings Preview